Department of General Surgery, Mayo Clinic, Rochester, MN 55902, USA.
J Gastrointest Surg. 2013 Jan;17(1):110-6; discussion p.116-7. doi: 10.1007/s11605-012-2011-6. Epub 2012 Aug 25.
Based on a previous published data on small bowel obstruction (SBO), a management model for predicting the need for exploration has been adopted in our institution. In our model, patients presenting with three criteria-the history of obstipation, the presence of mesenteric edema, and the lack of small bowel fecalization on computed tomography (CT)-undergo exploration. Patients with two or less features were managed nonoperatively. An alternative tool for predicting need for operative intervention is Gastrografin (GG) challenge test.
We hypothesized that the GG challenge test, when used in combination with our prior model, will decrease the rate of explorations in patients not meeting the criteria for immediate operation.
An approval from IRB was obtained to review patients admitted with a diagnosis of SBO from November 2010 to September 2011. All patients presenting with signs of ischemia, patients with all three model criteria defined previously, and those who had an abdominal operation within 6 weeks of diagnosis were excluded. All patients had an abdominal/pelvic CT and GG challenge at the time of diagnosis. Patients were compared to historic controls managed without the GG challenge (from July to December 2009). Successful GG challenge was defined as the presence of contrast in the colon after a follow-up film or a bowel movement. Data were presented as medians or percentages; significance was considered at p < 0.05.
One hundred and twenty-five patients with a diagnosis of small bowel obstruction were identified wherein 47 % were males. Fifty-three received a GG challenge (study), and 72 did not have a GG challenge (historic). There was no difference in age (70 vs 65 years), history of prior SBO (51 vs 49 %), history of diabetes mellitus (21 vs 18 %), history of malignancy (32 vs 39 %), or cardiac disease (30 vs 39 %). Both groups had similar number of previous abdominal operations (two vs two). The presence of mesenteric edema (68 vs 75 %), the lack of small bowel fecalization (47 vs 46 %), and a history of obstipation (25 vs 24 %) were similar in both groups. Patients in the study group had a lesser rate of abdominal exploration (25 vs 42 %, p = 0.05) and fewer complications (13 vs 31 %, p = 0.02) compared to the historic control group. There was equivalent incidence of ischemic bowel (4 vs 7 %), duration of hospital stay (4 vs 7 days), duration from admission to operation (2 vs 3 days), and mortality (8 vs 6 %); 44 patients had a successful GG challenge with nine failures. There was a greater rate of exploration in patients with a failed challenge compared to those with a successful challenge (89 vs 11 %, p < 0.01).
The use of the GG challenge enhanced the SBO prediction model by decreasing the need for exploration in patients not meeting the criteria for immediate operation. Patients who failed the GG challenge test were much more likely to undergo an exploration.
基于先前发表的关于小肠梗阻(SBO)的数据,我们的机构采用了一种用于预测探查需求的管理模型。在我们的模型中,出现以下三个标准的患者——便秘史、肠系膜水肿和 CT 上未见小肠粪便化——需要进行探查。具有两个或更少特征的患者进行非手术治疗。另一种预测手术干预需求的工具是泛影葡胺(GG)挑战试验。
我们假设,当 GG 挑战试验与我们之前的模型一起使用时,将降低不符合立即手术标准的患者进行探查的比率。
获得了 IRB 的批准,以回顾 2010 年 11 月至 2011 年 9 月期间因 SBO 入院的患者。所有出现缺血迹象的患者、具有之前定义的所有三个模型标准的患者以及在诊断后 6 周内进行腹部手术的患者均被排除。所有患者在诊断时均进行了腹部/骨盆 CT 和 GG 挑战检查。将患者与未接受 GG 挑战检查的历史对照(2009 年 7 月至 12 月)进行比较。成功的 GG 挑战被定义为在后续胶片或排便后结肠内有对比剂。数据以中位数或百分比表示;p<0.05 时认为有统计学意义。
共确定了 125 例小肠梗阻患者,其中 47%为男性。53 例接受了 GG 挑战(研究组),72 例未进行 GG 挑战(历史对照组)。两组的年龄(70 岁 vs 65 岁)、既往 SBO 史(51% vs 49%)、糖尿病史(21% vs 18%)、恶性肿瘤史(32% vs 39%)或心脏病史(30% vs 39%)无差异。两组的既往腹部手术次数相似(均为 2 次)。研究组的肠系膜水肿(68% vs 75%)、小肠粪便化缺失(47% vs 46%)和便秘史(25% vs 24%)相似。与历史对照组相比,研究组的腹部探查率较低(25% vs 42%,p=0.05),并发症较少(13% vs 31%,p=0.02)。两组的缺血性肠病发生率(4% vs 7%)、住院时间(4 天 vs 7 天)、从入院到手术的时间(2 天 vs 3 天)和死亡率(8% vs 6%)相似;44 例 GG 挑战成功,9 例失败。与成功挑战相比,失败挑战的患者更有可能进行探查(89% vs 11%,p<0.01)。
GG 挑战的使用通过减少不符合立即手术标准的患者的探查需求,增强了 SBO 预测模型。未通过 GG 挑战试验的患者更有可能进行探查。